Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016…

Overview of attention for article published in Breast cancer targets and therapy, December 2018

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 42 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 789 followers.

Primary systemic therapy in HER2-positive operable breast cancer using | BCTT - Dove Medical Press https://t.co/3mdH8B4yiF

Reply Repost Favourite